AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
NEW YORK & SUZHOU, China--(BUSINESS WIRE)--AnHeart Therapeutics (“AnHeartâ€), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with...

West Indies Capitalise on Dhaka Dominance as Bangladesh Fight for Survival in Sylhet
Brown’s late block lifts 76ers past Pistons as LeBron makes 16,000 mark
Chinese tape maker Crown New Materials surges 787% in Shenzhen debut, creating paper billionaires
Ekadashi kab hai in 2026: Rama on Nov 5, Devutthana on Nov 20, Papankusha on Oct 22
Navy Court-Martials Captain, Lieutenant Commander Over INS Brahmaputra Capsizing 





























